Skip to main content
Top
Published in: Internal and Emergency Medicine 6/2018

01-09-2018 | EM - ORIGINAL

Emergency department visits among patients with left ventricular assist devices

Authors: Christopher R. Tainter, Oscar Ö. Braun, Felipe Teran, Albert P. Nguyen, Kimberly Robbins, Edward O. O’Brien, Zeb M. McMillan, Ulrich Schmidt, Angela Meier, Mat Goebel, Victor Pretorius, Michela Brambatti, Eric D. Adler, Raghu Seethala

Published in: Internal and Emergency Medicine | Issue 6/2018

Login to get access

Abstract

Continuous-flow left ventricular assist devices (LVADs) are increasingly implanted to support patients with end-stage heart failure. These patients are at high risk for complications, many of which necessitate emergency care. While rehospitalization rates have been described, there is little data regarding emergency department (ED) visits. We hypothesize that ED visits are frequent and often require admission after LVAD implantation. We performed a retrospective review of patients in our health-care system followed by the advanced heart failure service for LVAD management after implantation between January 2011 and July 2015. We accounted for all ED visits in our system through February 2016, 7 months after the last implantation included. Clinically relevant demographic variables and ED visit details were recorded and analyzed to describe this population. We identified 81 patients with complete data, among whom there were 283 visits (3.49 visits/patient), occurring at a rate of approximately 7.3 ED visits per patient per year alive with LVAD. The most common reason for an ED visit is a complication related to bleeding (18% of visits), followed by chest pain (14%) and dizziness or syncope (13%). Thirty-six percent of patients were discharged from the ED without hospital admission. A growing populace with implanted LVADs represents an important population within emergency medicine. They are at risk for significant complications and frequently present to the ED. While many of these visits may be managed without hospital admission, this specialized patient group represents a potential area for improvement in provider education.
Literature
1.
go back to reference Rose EA, Gelijns AC, Moskowitz AJ et al (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345(20):1435–1443CrossRefPubMed Rose EA, Gelijns AC, Moskowitz AJ et al (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345(20):1435–1443CrossRefPubMed
2.
go back to reference Aaronson KD, Slaughter MS, Miller LW et al (2012) Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 125(25):3191–3200CrossRefPubMed Aaronson KD, Slaughter MS, Miller LW et al (2012) Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 125(25):3191–3200CrossRefPubMed
3.
go back to reference Miller LW, Pagani FD, Russell SD et al (2007) Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357(9):885–896CrossRefPubMed Miller LW, Pagani FD, Russell SD et al (2007) Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357(9):885–896CrossRefPubMed
5.
go back to reference Forest SJ, Bello R, Friedmann P et al (2013) Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital. Ann Thorac Surg 95(4):1276–1281CrossRefPubMed Forest SJ, Bello R, Friedmann P et al (2013) Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital. Ann Thorac Surg 95(4):1276–1281CrossRefPubMed
6.
go back to reference Hasin T, Marmor Y, Kremers W et al (2013) Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol 61(2):153–163CrossRefPubMed Hasin T, Marmor Y, Kremers W et al (2013) Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol 61(2):153–163CrossRefPubMed
7.
go back to reference Smedira NG, Hoercher KJ, Lima B et al (2013) Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival. JACC Heart Fail 1(1):31–39CrossRefPubMed Smedira NG, Hoercher KJ, Lima B et al (2013) Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival. JACC Heart Fail 1(1):31–39CrossRefPubMed
8.
go back to reference Akhter SA, Badami A, Murray M et al (2015) Hospital readmissions after continuous-flow left ventricular assist device implantation: incidence, causes, and cost analysis. Ann Thorac Surg 100(3):884–889CrossRefPubMed Akhter SA, Badami A, Murray M et al (2015) Hospital readmissions after continuous-flow left ventricular assist device implantation: incidence, causes, and cost analysis. Ann Thorac Surg 100(3):884–889CrossRefPubMed
9.
go back to reference Hernandez RE, Singh SK, Hoang DT et al (2015) Present-day hospital readmissions after left ventricular assist device implantation: a Large Single-Center Study. Tex Heart Inst J 42(5):419–429CrossRefPubMedPubMedCentral Hernandez RE, Singh SK, Hoang DT et al (2015) Present-day hospital readmissions after left ventricular assist device implantation: a Large Single-Center Study. Tex Heart Inst J 42(5):419–429CrossRefPubMedPubMedCentral
10.
go back to reference Da Silva M, MacIver J, Rodger M et al (2016) Readmissions following implantation of a continuous-flow left ventricular assist device. J Card Surg 31(5):361–364CrossRefPubMed Da Silva M, MacIver J, Rodger M et al (2016) Readmissions following implantation of a continuous-flow left ventricular assist device. J Card Surg 31(5):361–364CrossRefPubMed
11.
go back to reference Hing E, Rui P (2016) Emergency department use in the country’s five most populous states and the total United States, 2012. Hyattsville: National Center for Health Statistics. Accessed Sept 23, 2017 Hing E, Rui P (2016) Emergency department use in the country’s five most populous states and the total United States, 2012. Hyattsville: National Center for Health Statistics. Accessed Sept 23, 2017
12.
go back to reference Demirozu ZT, Radovancevic R, Hochman LF et al (2011) Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 30(8):849–853PubMed Demirozu ZT, Radovancevic R, Hochman LF et al (2011) Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 30(8):849–853PubMed
13.
go back to reference Harvey L, Holley CT, John R (2014) Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention. Ann Cardiothorac Surg 3(5):475–479PubMedPubMedCentral Harvey L, Holley CT, John R (2014) Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention. Ann Cardiothorac Surg 3(5):475–479PubMedPubMedCentral
14.
go back to reference Mehra MR, Naka Y, Uriel N et al (2017) A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med 376(5):440–450CrossRefPubMed Mehra MR, Naka Y, Uriel N et al (2017) A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med 376(5):440–450CrossRefPubMed
Metadata
Title
Emergency department visits among patients with left ventricular assist devices
Authors
Christopher R. Tainter
Oscar Ö. Braun
Felipe Teran
Albert P. Nguyen
Kimberly Robbins
Edward O. O’Brien
Zeb M. McMillan
Ulrich Schmidt
Angela Meier
Mat Goebel
Victor Pretorius
Michela Brambatti
Eric D. Adler
Raghu Seethala
Publication date
01-09-2018
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 6/2018
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-017-1776-8

Other articles of this Issue 6/2018

Internal and Emergency Medicine 6/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.